Cover Image
市場調查報告書

院內感染管理市場(殺菌·消毒·檢驗·治療)

The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment)

出版商 Kalorama Information 商品編碼 278892
出版日期 內容資訊 英文 230 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
院內感染管理市場(殺菌·消毒·檢驗·治療) The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment)
出版日期: 2013年08月09日 內容資訊: 英文 230 Pages
簡介

考慮到院內感染·醫療相關感染(HAI)的成本,醫療產業上削減感染及感染相關成本的有效解決方案需求正在高漲。美國的疾病對策中心(CDC)推測住院患者大約20人中就有1位或5%得到HAI的病。全球先進地區上人院患者院内感染率從3.5%到12%,該事態創造了檢查·治療·預防這些感染疾病的企業市場機會。

本報告網羅醫療保健現場最常蔓延的感染疾病類型中細菌性院內感染整體資料,將重點放在預防、檢查及治療醫療環境的感染疾病調查上,提供主要市場機會,並彙整主要企業簡介等,為您概述為以下內容。

第1章 摘要整理

第2章 簡介·產業趨勢

  • 概要
  • 病原體的簡介
  • 全球人口統計
  • 感染疾病的說明
  • 感染風險評估:醫院的各部門
  • 護理機構的國際趨勢
  • 經濟趨勢
  • 醫療費及實際醫療轉換期的比較
  • 為了預防醫療相關感染(HAI),美國政府的國家計劃
  • 相關案例研究
  • 感染疾病和藥物抗性
  • 主要人口族群上的藥物抗性
  • 減少抗性的方法
  • 住院患者的篩檢
  • 醫藥品廠商·市場行銷趨勢

第3章 預防感染

  • 概要
  • 感染方法
  • 高風險的設備·工作崗位
  • 技術概要
  • 殺菌vs.消毒
  • 設備·解決方案
  • 熱/蒸氣殺菌
  • 化學藥品殺菌
  • 放射線殺菌
  • 市場概要
  • 院內預防感染市場:各地區
  • 競爭分析

第4章 感染檢驗

  • 概要
  • 藥物抗性/敏度檢查
  • 特定嚴重院內感染檢驗
  • 結核
  • 新的開發趨勢
  • 市場概要
  • 整體市場規模與預測
  • 院內感染檢驗市場:各地區
  • 競爭分析

第5章 感染治療

  • 概要
  • 抗菌治療的原理
  • 感染微生物學
  • 抗菌產品的分類
  • 治療指南
  • 主要產品

第6章 院內感染管理的市場機會

  • 市場討論事項
  • 市場概要
  • 院內感染管理市場:各地區

第7章 企業簡介

  • 簡介
  • Advanced Sterilization Products
  • Becton, Dickinson
  • Belimed
  • bioMerieux
  • Cantel
  • Cepheid
  • Getinge Group
  • Kimberly-Clark
  • Merck & Co
  • Nordion
  • Pfizer
  • Roche
  • Sakura Seiki
  • Steris
  • Tso3

圖表清單

目錄
Product Code: KLI5094606

Given the cost of hospital-acquired and healthcare-associated infections (HAIs), demand has increased for solutions that can help the healthcare industry reduce infections and the costs associated with them. The U.S. Centers for Disease Control and Prevention (CDC) estimates that around 1 in 20 or 5% of hospitalized patients will contract an HAI. Worldwide, the rate of nosocomial infections is between 3.5% and 12% of admissions in developed regions. This has created a market opportunity for companies that can test for, treat and help prevent these infections. This opportunity is detailed in Kalorama Information's report, The Market for Hospital-Acquired Infection Control (Sterilization, Cleaning, Testing, Treatment)

This report focuses on preventing, testing and treating infections in the healthcare environment. The major consideration is given to bacterial nosocomial infections because a) they are the most frequent type of infections spread in the health care delivery setting, and b) the practical aspects of diagnosis and therapy are more meaningful based on a combination of medical and financial considerations.

The report will provide a market analysis for each of the three areas:

  • Prevention
  • Testing
  • Treatment

The infection control market is a stable one for companies involved in these areas. As long as there are infections there will always be a need for controlling these infections. It is a fact that diseases evolve and that new approaches to preventing, diagnosing and treating will be required for the long-term.

Market analysis in this report considers primarily the epidemiological considerations and the size patient groups both in the United States and globally, where available. We have accumulated the most recent data available, understanding that virtually no organization does extensive studies on these applications on a regular basis.

Many studies are highly localized and may only apply to a community, state or country (more often countries that are not a part of the major markets for nosocomial diagnostic and therapeutic products). In many instances, we have had to draw from broader epidemiologic data, that is, on data that reach outside of the hospital and primary care environment in order to construct a picture of the infection prevention, testing and treatment needs.

In looking at infections in the health environment, we consider the diagnostic and therapeutic technologies that are currently available and attempt to project trends for preventing, detecting and treating these infections. To some extent, we are limited by the activity of the industries associated with the activities mentioned above for these infections. For the most part, these activities are limited and the advanced technologies seen in other areas of medical application are not necessarily present in terms of microbiology.

The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from extensive literature reviews and discussions with experts in the field, including microbiologists, pathologists, hospital authorities, reimbursement specialists, research scientists, business development managers and marketing managers.

The majority of competitive participation for Hospital-Acquired Infection control and is in the United States and Europe. However, competition is steadily escalating in the United States and Europe, which is encouraging more participation in other areas such as Asia and Latin America.

Companies included in this report are:

  • Advanced Sterilization Products
  • Becton Dickinson
  • Belimed AG
  • bioMerieux
  • Cantel
  • Cepheid
  • Getinge
  • Kimberly-Clark
  • Merck & Co.
  • Nordion
  • Pfizer
  • Roche
  • Sakura Seiki
  • Steris
  • TSO3

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

  • Overview
  • The Nosocomial Infection
  • Scope and Methodology
  • Total Size and Growth of the Market
  • Issues and Trends Affecting Market
  • Leading Competitors

CHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDS

  • Overview
  • Introduction to Pathogens
  • Classification of Antibacterial Organisms
  • Patient Risk Factors
  • General Infection Statistics
  • Populations at Risk for Infection
  • Demographics of the World
  • Life Expectancy
  • Nosocomial Infection Statistics
  • Common Hospital (nosocomial) Infections
  • Description of Infections
  • Infection Risk Assessments by Hospital Department
  • Burn Units
  • Intensive Care Units
  • Emergency Departments
  • Hospital Length of Stay
  • Extended Stay Environments
  • International Trends in Nursing Facilities
  • Economic Trends
  • Comparison Between Healthcare Spending and Real Health Outcomes
  • U.S. Government's National Plan to Prevent Healthcare Associated Infections (HAIs)
  • Steering Committee
  • The American Recovery and Reinvestment Act of 2009
  • Affordable Care Act (ACA) Funding
  • Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Funding
  • U.S. Statewide Standardized Infection Ratio
  • Reduction in Hospital Acquired Infections
  • Reduction in Infections in Israel
  • Burden of Hospital Acquired Infections
  • Hospital-Acquired Infection Surveillance Process
  • Case Studies
  • Arizona Prevention Study
  • Connecticut Funding for HAI Prevention and Reporting
  • Pennsylvania Study of HAI Admissions and Readmissions
  • Infections and Drug Resistance
  • Easing Approvals of Antibiotics
  • Causes of Drug Resistance
  • Antibiotic Abuse
  • Antibiotic Use in Agriculture
  • Drug Resistance in Select Populations
  • Children
  • The Elderly
  • Compromised Individuals
  • Measures for Reducing Resistance
  • Testing for the Selection of Anti-bacterial Therapy
  • Monitoring Therapy
  • Screening Hospitalized patients
  • Pharmaceutical Manufacturer and Marketer Trends
  • Trends in Partnerships and Alliances
  • Developers Trends

CHAPTER THREE: INFECTION PREVENTION

  • Overview
  • Methods of Transmission
  • Airborne
  • Contact
  • Droplet
  • Vehicle
  • High-Risk Facilities or Departments
  • Technology Overview
  • Potential Use of Copper for Reducing Infections
  • Wide Area Disinfection Methods
  • Software for Infection Detection and Control
  • Antiseptic-Coated Catheters
  • Sterilization vs. Disinfection
  • Sterilization
  • Disinfection
  • Equipment and Solutions
  • Heat/Steam Sterilization
  • Developments
  • Chemical Sterilization
  • Sterilants
  • Developments
  • Radiation Sterilization
  • Developments
  • Market Overview
  • Hospital-Acquired Infection Prevention Market by Geographical Region
  • Competitive Analysis

CHAPTER FOUR: INFECTION TESTING

  • Overview
  • Drug-Resistance/Susceptibility Testing
  • Genotypic Methods
  • DNA Sequencing
  • Solid-phase Hybridization Techniques
  • Microarrays
  • Real-time Polymerase Chain Reaction Techniques
  • Phenotypic Methods
  • Phage-based Assays
  • Colorimetric Methods
  • The Nitrate Reductase Assay
  • Specific Serious Hospital-Acquired Infection Testing
  • Acinetobacter Baumannii
  • Clostridium Difficile
  • Developments
  • Hospital-Acquired Pneumonia
  • Pseudomonas Aeruginosa
  • Staphylococcus Aureus
  • Methicillin-resistant Staphylococcus Aureus (MRSA)
  • Vancomycin-Intermediate/Resistant Staphylococcus Aureus (VISA/VRSA)
  • Developments
  • Tuberculosis
  • Developments
  • Urinary Tract Infections
  • Vancomycin-resistant Enterococcus
  • Developments
  • Ventilator-Associated Pneumonia
  • New Developments
  • Market Overview
  • Total Market Size and Forecast
  • Hospital-Acquired Infection Testing Market by Geographical Region
  • Competitive Analysis

CHAPTER FIVE: INFECTION TREATMENT

  • Overview
  • Principles of Anti-bacterial Therapy
  • Infecting Organism
  • Antibiotic Sensitivity Testing
  • Site of Infection
  • Host Defenses and Organ Function
  • Antibiotic Pharmacokinetics
  • Monitoring Therapy
  • Classifications of Antibacterial Products
  • Carbapenems
  • Cephalosporins
  • Macrolides
  • Penicillins
  • Quinolones
  • Sulfonamides
  • Tetracyclines
  • Treatment Guidelines
  • Clostridium Difficile
  • Gastroenteritis
  • Hospital-Acquired Pneumonia
  • Ventilator-associated Pneumonia
  • Pseudomonas Aeruginosa
  • Staphylococcus Aureus
  • Stenotrophomonas maltophilia
  • Tuberculosis
  • Urinary Tract Infections
  • Leading Products
  • New Developments
  • Total Market Size and Forecast
  • Hospital-Acquired Infection Treatment Market by Geographical Region
  • Competitive Analysis

CHAPTER SIX: MARKET OPPORTUNITIES FOR HOSPITAL-ACQUIRED INFECTION CONTROL

  • Market Considerations
  • Market Overview
  • Hospital-Acquired Infection Control Market by Geographical Region

CHAPTER SEVEN: COMPANY PROFILES

  • Introduction
  • Advanced Sterilization Products
  • Company Performance
  • Becton, Dickinson
  • Company Performance
  • Belimed
  • Company Performance
  • bioMerieux
  • Company Performance
  • Cantel
  • Company Performance
  • Cepheid
  • Company Performance
  • Getinge Group
  • Company Performance
  • Kimberly-Clark
  • Company Performance
  • Merck & Co
  • Company Performance
  • Nordion
  • Company Performance
  • Pfizer
  • Company Performance
  • Roche
  • Company Performance
  • Sakura Seiki
  • Steris
  • Company Performance
  • Tso3
  • Company Performance

LIST OF MAJOR PROVIDERS

Back to Top